Rakesh Madhav CFA25th Nov Β· SEBI-Registered AnalystInvest with Rakesh Neloor Β· 25th NovFollowπ Follow-Up Update: Bliss GVS Pharma β Momentum Re-IgnitedPrice: βΉ172 View: Bullish follow-up π Whatβs happening now? BLISSGVS has delivered a strong follow-through move after last weekβs breakout recovery. Price reclaimed the βΉ170 zone with solid volume support, showing buyers are firmly defending the recent dip. π Technical Setup RSI β 61.7, trending upward, indicating renewed strength. RSI SMA β 52.8, bullish crossover. OBV rising sharply β confirms genuine accumulation after panic candle. Structure: Higher-lows intact; stock firing towards the βΉ195ββΉ200 supply zone. Supports: βΉ160 β βΉ148 Resistance: βΉ185 β βΉ197 π§© Fundamentals Strong presence in anti-malarial & womenβs health products. Robust export business drives consistent margins. Debt-light balance sheet keeps valuations reasonable. π Analyst View Most analysts maintain a BUY/HOLD, citing steady earnings and improving export order book. π Conclusion: Momentum has revived. Sustaining above βΉ170 keeps the next leg towards βΉ190ββΉ200 alive.#SectorBreakouts#EquityResearch#TechnicalViews#FundamentalViews800 likesΒ·38 comments